These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32788311)

  • 41. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.
    Ramanathan RS; Rana S
    Neurodegener Dis Manag; 2018 Feb; 8(1):17-23. PubMed ID: 29316850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Junior medical doctors' decision making when using advance care directives to guide treatment for people with dementia: a cross-sectional vignette study.
    Waller A; Bryant J; Bowman A; White BP; Willmott L; Pickles R; Hullick C; Price E; Knight A; Ryall MA; Clapham M; Sanson-Fisher R
    BMC Med Ethics; 2022 Jul; 23(1):73. PubMed ID: 35836232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Racial differences in motor neuron disease.
    Gundogdu B; Al-Lahham T; Kadlubar F; Spencer H; Rudnicki SA
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):114-8. PubMed ID: 24067242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients' perspectives of multidisciplinary home-based e-Health service delivery for motor neurone disease.
    James N; Power E; Hogden A; Vucic S
    Disabil Rehabil Assist Technol; 2019 Oct; 14(7):737-743. PubMed ID: 30182780
    [No Abstract]   [Full Text] [Related]  

  • 45. Advance care planning in motor neuron disease: A systematic review.
    Murray L; Butow PN
    Palliat Support Care; 2016 Aug; 14(4):411-32. PubMed ID: 26462880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of two different methods for per-oral gastrostomy tube placement in patients with motor neuron disease (MND): PIG versus PEG procedures.
    Chavada G; El-Nayal A; Lee F; Webber SJ; McAlindon M; Walsh T; Hollinger H; McDermott CJ; Shaw PJ
    Amyotroph Lateral Scler; 2010 Dec; 11(6):531-6. PubMed ID: 20553092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decision-making for gastrostomy and ventilatory support for people with motor neurone disease: variations across UK hospices.
    Oliver D; Campbell C; Sykes N; Tallon C; Edwards A
    J Palliat Care; 2011; 27(3):198-201. PubMed ID: 21957796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Palliative care health professionals' experiences of caring for patients with advance care directives.
    Johnson CE; Singer R; Masso M; Sellars M; Silvester W
    Aust Health Rev; 2015 Apr; 39(2):154-159. PubMed ID: 25607507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings.
    Jeong S; Ohr SO; Cleasby P; Barrett T; Davey R; Deeming S
    BMC Health Serv Res; 2021 Jul; 21(1):729. PubMed ID: 34301254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advance care directive documentation: issues for clinicians in New South Wales.
    Friedewald MI; Cleasby PA
    Aust Health Rev; 2018 Feb; 42(1):89-92. PubMed ID: 28147212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of advance care planning documentation and self-reported uptake in older Australians with a cancer diagnosis.
    Detering KM; Sellars M; Kelly H; Clayton JM; Buck K; Nolte L
    J Geriatr Oncol; 2021 Mar; 12(2):274-281. PubMed ID: 32739354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reviewing evidences on the management of patients with motor neuron disease.
    Lee CN
    Hong Kong Med J; 2012 Feb; 18(1):48-55. PubMed ID: 22302912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and predictors of advance directives in Australia.
    White B; Tilse C; Wilson J; Rosenman L; Strub T; Feeney R; Silvester W
    Intern Med J; 2014 Oct; 44(10):975-80. PubMed ID: 25109226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Residential aged care residents and components of end of life care in an Australian hospital.
    Leong LJP; Crawford GB
    BMC Palliat Care; 2018 Jun; 17(1):84. PubMed ID: 29885669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DSP-01 Barriers to the diagnosis of motor neuron disease - a South Australian study.
    Sharrad DF; Schultz DW
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(sup1):289-300. PubMed ID: 31702473
    [No Abstract]   [Full Text] [Related]  

  • 56. Assisted ventilation in motor neurone disease during inpatient palliative care: barriers and utilisation.
    Gleeson A; Johnson F
    BMJ Support Palliat Care; 2020 Sep; 10(3):358-362. PubMed ID: 30712020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective cohort study of the effect of medical emergency teams on documentation of advance care directives.
    Knott CI; Psirides AJ; Young PJ; Sim D
    Crit Care Resusc; 2011 Sep; 13(3):167-74. PubMed ID: 21880004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of advance care directives in the community: a telephone survey of three Australian States.
    White BP; Willmott L; Tilse C; Wilson J; Ferguson M; Aitken J; Dunn J; Lawson D; Pearce A; Feeney R
    Intern Med J; 2019 Oct; 49(10):1261-1267. PubMed ID: 30785233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
    McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S
    Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.